Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325): EPA/DHA/DPA related health claims

Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits

Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966 · see citing works

Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol

EFSA Panel on Dietetic Products, N. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1461 · Cited by 1,295 · see citing works

Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention

Harris, W. S., Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, L. L., Appel, L. J., Engler, M. M., Engler, M. B., & Sacks, F. (2009) · Circulation · doi:10.1161/circulationaha.108.191627 · Cited by 794 · see citing works

Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids

Harris, W. S., Mozaffarian, D., Lefevre, M., Toner, C. D., Colombo, J., Cunnane, S. C., Holden, J. M., Klurfeld, D. M., Morris, M. C., & Whelan, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.101329 · Cited by 356 · see citing works

Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults

Harris, W. S., Kris‐Etherton, P. M., & Harris, K. A. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0078-z · Cited by 196 · see citing works

Fish and n−3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death

Mozaffarian, D. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.6.1991s · Cited by 181 · see citing works

Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy

Stark, K. D., & Holub, B. J. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.765 · Cited by 177 · see citing works

Dietary Fish Oil Reduces Basal and Ultraviolet B-Generated PGE2 Levels in Skin and Increases the Threshold to Provocation of Polymorphic Light Eruption

Rhodes, L. E., Durham, B., Fraser, W. D., & Friedmann, P. S. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12323389 · Cited by 141 · see citing works

Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers

Rhodes, L. E. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg038 · Cited by 118 · see citing works

Impact of foods enriched with<i>n</i>-3 long-chain polyunsaturated fatty acids on erythrocyte<i>n</i>-3 levels and cardiovascular risk factors

Murphy, K. J., Meyer, B. J., Mori, T. A., Burke, V., Mansour, J., Patch, C. S., Tapsell, L. C., Noakes, M., Clifton, P. A., Barden, A., et al. (2007) · British Journal Of Nutrition · doi:10.1017/s000711450747252x · Cited by 110 · see citing works

Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid dose-dependently reduce fasting serum triglycerides.

Musa-Veloso, K., Binns, M. A., Kocenas, A. C., Poon, T., Elliot, J. A., Rice, H., Oppedal-Olsen, H., Lloyd, H., & Lemke, S. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00272.x · Cited by 73 · see citing works

Effects of docosahexaenoic acid supplementation on blood lipids, estrogen metabolism, and in vivo oxidative stress in postmenopausal vegetarian women.

Wu, W. H., Lu, S. C., Wang, T. F., Jou, H. J., & Wang, T. A. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602328 · Cited by 70 · see citing works

The potential of omega-3 fatty acids in the prevention of non-melanoma skin cancer

Black, H. S., & Rhodes, L. E. (2006) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.04.008 · Cited by 69 · see citing works

Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women with Below Average Levels of High Density Lipoprotein Cholesterol

Maki, K. C., Elswyk, M. E. V., McCarthy, D., Hess, S. P., Veith, P. E., Bell, M., Subbaiah, P. V., & Davidson, M. H. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719465 · Cited by 67 · see citing works

Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects

Goyens, P. L. L., & Mensink, R. P. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602408 · Cited by 62 · see citing works

Lipid Responses in Mildly Hypertriglyceridemic Men and Women to Consumption of Docosahexaenoic Acid-Enriched Eggs

Maki, Elswyk, V., McCarthy, Seeley, Veith, Hess, Ingram, I., Halvorson, Calaguas, & Davidson (2003) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.73.5.357 · Cited by 47 · see citing works

n−3 long‐chain FA decrease serum levels of TG and remnant‐like particle‐cholesterol in humans

Hamazaki, K., Itomura, M., Huan, M., Nishizawa, H., Watanabe, S., Hamazaki, T., Sawazaki, S., TERASAWA, K., Nakajima, S., Terano, T., et al. (2003) · Lipids · doi:10.1007/s11745-003-1069-x · Cited by 41 · see citing works

Topical and systemic approaches for protection against solar radiation-induced skin damage

Rhodes, L. E. (1998) · Clinics in Dermatology · doi:10.1016/s0738-081x(97)00171-5 · Cited by 33 · see citing works

Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia

de Castro, I. A., Monteiro, V. C. B., Barroso, L. P., & Bertolami, M. C. (2007) · Nutrition · doi:10.1016/j.nut.2006.11.006 · Cited by 19 · see citing works

Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020

Innes, J. K., & Calder, P. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041362 · Cited by 382 · see citing works

Dietary enrichment of eggs with omega-3 fatty acids: A review

Fraeye, I., Bruneel, C., Lemahieu, C., Buyse, J. G., Muylaert, K., & Foubert, I. (2012) · Food Research International · doi:10.1016/j.foodres.2012.03.014 · Cited by 299 · see citing works

Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health

EFSA Panel on Dietetic Products, N. A. A. (. N. P., Turck, D., Bresson, J., Burlingame, B., Dean, T., Fairweather‐Tait, S. J., Heinonen, M., Hirsch‐Ernst, K. I., Mangelsdorf, I., McArdle, H. J., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5136 · Cited by 149 · see citing works

A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals

Leslie, M. A., Cohen, D. J. A., Liddle, D. M., Robinson, L. E., & Ma, D. W. L. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0049-7 · Cited by 143 · see citing works

Some strategies for the stabilization of long chain n‐3 PUFA‐enriched foods: A review

Jacobsen, C. (2015) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201500137 · Cited by 126 · see citing works

Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials

AbuMweis, S., Jew, S., Tayyem, R., & Agraib, L. (2018) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12493 · Cited by 122 · see citing works

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Cicero, A. F. G., Fogacci, F., Stoian, A. P., Vrablik, M., Al Rasadi, K., Banach, M., Toth, P. P., & Rizzo, M. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00955-y · Cited by 110 · see citing works

General scientific guidance for stakeholders on health claim applications (Revision 1)1

EFSA Panel on Dietetic Products, N. A. A. (. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6553 · Cited by 96 · see citing works

Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data

Cicero, A. F. G., & Colletti, A. (2016) · Phytomedicine · doi:10.1016/j.phymed.2015.10.011 · Cited by 70 · see citing works

Protective effect of the omega-3 polyunsaturated fatty acids: Eicosapentaenoic acid/Docosahexaenoic acid 1:1 ratio on cardiovascular disease risk markers in rats

Lluís, L., Taltavull, N., Muñoz-Cortés, M., Sánchez‐Martos, V., Romeu, M., Giralt, M., Molinar‐Toribio, E., Torres, J. L., Pérez‐Jiménez, J., Pazos, M., et al. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-140 · Cited by 68 · see citing works

Scientific advice related to nutrient profiling for the development of harmonised mandatory front‐of‐pack nutrition labelling and the setting of nutrient profiles for restricting nutrition and health claims on foods

EFSA Panel on Nutrition, N. F. A. F. A. (., Turck, D., Bohn, T., Castenmiller, J. J. M., Henauw, S. D., Hirsch‐Ernst, K. I., Knutsen, H. K., Maciuk, A., Mangelsdorf, I., McArdle, H. J., et al. (2022) · EFSA Journal · doi:10.2903/j.efsa.2022.7259 · Cited by 67 · see citing works

Nutraceuticals for older people: Facts, fictions and gaps in knowledge

González‐Sarrías, A., Larrosa, M., García‐Conesa, M., Tomás-Barberán, F. A., & Espı́n, J. C. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.05.006 · Cited by 66 · see citing works

Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: Do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials

Casula, M., Olmastroni, E., Gazzotti, M., Galimberti, F., Zambon, A., & Catapano, A. L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105060 · Cited by 54 · see citing works

Reduced protein oxidation in Wistar rats supplemented with marine ω3 PUFAs

Méndez, L., Pazos, M., Gallardo, J. M., Torres, J. L., Pérez‐Jiménez, J., Nogués, R., Romeu, M., & Medina, I. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.004 · Cited by 53 · see citing works

The effect of partial-fat substitutions with encapsulated and unencapsulated fish oils on the technological and eating quality of beef burgers over storage.

Keenan, D. F., Resconi, V., Smyth, T., Botinestean, C., Lefranc, C., Kerry, J., & Hamill, R. (2015) · Meat Science · doi:10.1016/j.meatsci.2015.04.013 · Cited by 48 · see citing works

The Impacts of Cholesterol, Oxysterols, and Cholesterol Lowering Dietary Compounds on the Immune System

Yanagisawa, R., He, C., Asai, A., Hellwig, M., Henle, T., & Toda, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012236 · Cited by 47 · see citing works

Sustainability vs. Quality in gilthead seabream (Sparus aurata L.) farming: are trade‐offs inevitable?

Matos, E., Dias, J. P., Dinis, M. T., & Silva, T. S. (2016) · Reviews in Aquaculture · doi:10.1111/raq.12144 · Cited by 46 · see citing works

Nanoliposomes, from food industry to nutraceuticals: Interests and uses

Bondu, C., & Yen, F. T. (2022) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2022.103140 · Cited by 45 · see citing works

Functional Foods in Europe: A Focus on Health Claims

Pravst, I. (2012) · Scientific, Health and Social Aspects of the Food Industry · doi:10.5772/31057 · Cited by 42 · see citing works

Seasonal changes in the fillet fatty acid profile and nutritional characteristics of wild Trasimeno Lake goldfish (Carassius auratus L.)

Bosco, A. D., Mugnai, C., Mourvaki, E., & Castellini, C. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.11.043 · Cited by 32 · see citing works

Cooking and nutritional science: Gastronomy goes further

Navarro, V., Serrano, G., Lasa, D., Aduriz, A. L., & Ayo, J. (2012) · International Journal of Gastronomy and Food Science · doi:10.1016/j.ijgfs.2011.11.004 · Cited by 32 · see citing works

Food and plant bioactives for reducing cardiometabolic disease: How does the evidence stack up?

Cicero, A. F. G., & Colletti, A. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.04.001 · Cited by 29 · see citing works

Effects of diets, foods and nutrients on immunity: Implications for COVID‐19?

Lockyer, S. (2020) · Nutrition Bulletin · doi:10.1111/nbu.12470 · Cited by 27 · see citing works

Prediction of fillet fatty acid composition of market-size gilthead sea bream (Sparus aurata) using a regression modelling approach

Ballester-Lozano, G. F., Benedito‐Palos, L., Navarro, J. C., Kaushik, S., & Pérez‐Sánchez, J. (2011) · Aquaculture · doi:10.1016/j.aquaculture.2011.06.015 · Cited by 26 · see citing works

“Planeterranea”: An attempt to broaden the beneficial effects of the Mediterranean diet worldwide

Vetrani, C., Piscitelli, P., Muscogiuri, G., Barrea, L., Laudisio, D., Graziadio, C., Marino, F., & Colao, A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.973757 · Cited by 25 · see citing works

Scientific Opinion on the extension of use for DHA and EPA‐rich algal oil from Schizochytrium sp. as a Novel Food ingredient

EFSA Panel on Dietetic Products, N. A. A. (. (2014) · EFSA Journal · doi:10.2903/j.efsa.2014.3843 · Cited by 25 · see citing works

Safety assessment of EPA+DHA canola oil by fatty acid profile comparison to various edible oils and fat-containing foods and a 28-day repeated dose toxicity study in rats

Andre, C., Buesen, R., Riffle, B., Wandelt, C., Sottosanto, J. B., Marxfeld, H., Strauss, V., van Ravenzwaay, B., & Lipscomb, E. A. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.11.042 · Cited by 24 · see citing works

Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study

Cicero, A. F. G., Derosa, G., Pisciotta, L., Barbagallo, C. M., & for the SISA-PUFACOL Study Group (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2015.0024 · Cited by 23 · see citing works

Clinical safety evaluation of marine oil derived from Calanus finmarchicus

Tande, K. S., Vo, T. D., & Lynch, B. S. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.05.030 · Cited by 20 · see citing works

An update on the safety of nutraceuticals and effects on lipid parameters

Cicero, A. F. G., & Colletti, A. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1429404 · Cited by 20 · see citing works

Splenic Immune Response Is Down-Regulated in C57BL/6J Mice Fed Eicosapentaenoic Acid and Docosahexaenoic Acid Enriched High Fat Diet

Soni, N. K., Ross, A. B., Scheers, N., Savolainen, O. I., Nookaew, I., Gabrielsson, B. G., & Sandberg, A. (2017) · Nutrients · doi:10.3390/nu9010050 · Cited by 18 · see citing works

Comparative Bioavailability of DHA and EPA from Microalgal and Fish Oil in Adults

Bailey, E., Wojcik, J., Rahn, M., Roos, F. F., Spooren, A., & Koshibu, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199343 · Cited by 20 · see citing works

Current Drugs and Nutraceuticals for the Treatment of Patients with Dyslipidemias

Scognamiglio, M., Costa, D., Sorriento, A., & Claudio Napoli, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190130101108 · Cited by 15 · see citing works

Marine oils: Complex, confusing, confounded?

Albert, B. B., Cameron‐Smith, D., Garg, M. L., Derraik, J. G. B., Hofman, P. L., & Cutfield, W. S. (2016) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2016.03.003 · Cited by 15 · see citing works

Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study

Grytten, E., Laupsa‐Borge, J., Bohov, P., Bjørndal, B., Strand, E., Skorve, J., Nordrehaug, J. E., Berge, R. K., Rostrup, E., Mellgren, G., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.040 · Cited by 14 · see citing works

Dietary n-3 polyunsaturated fatty acids alter the number, fatty acid profile and coagulatory activity of circulating and platelet-derived extracellular vesicles: a randomized, controlled crossover trial

Bozbaş, E., Zhou, R., Soyama, S., Allen‐Redpath, K., Mitchell, J. L., Fisk, H. L., Calder, P. C., Jones, C. I., Gibbins, J. M., Fischer, R., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.03.008 · Cited by 12 · see citing works

Strategies for Enzymatic Synthesis of Omega‐3 Structured Triacylglycerols from Camelina sativa Oil Enriched in EPA and DHA

Castejón, N., & Señoráns, F. J. (2019) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201800412 · Cited by 12 · see citing works

Development of Fatty Acid Reference Ranges and Relationship with Lipid Biomarkers in Middle-Aged Healthy Singaporean Men and Women

Lust, C. A. C., Bi, X., Henry, C. J., & David, W. L. (2021) · Nutrients · doi:10.3390/nu13020435 · Cited by 11 · see citing works

Dummy regression analysis for modelling the nutritionally tailored fillet fatty acid composition of turbot and sole using gilthead sea bream as a reference subgroup category

Ballester-Lozano, G. F., Benedito‐Palos, L., Riaza, A., Navarro, J. C., Rosel, J., & Pérez‐Sánchez, J. (2014) · Aquaculture Nutrition · doi:10.1111/anu.12095 · Cited by 11 · see citing works

Bioavailability of Orally Administered Active Lipid Compounds from four Different Greenshell™ Mussel Formats

Miller, M. R., Kruger, M. C., Wynne, C., Waaka, D., Li, W., Frampton, C., Wolber, F. M., & Eason, C. (2020) · Marine Drugs · doi:10.3390/md18110524 · Cited by 11 · see citing works

Toward determining fat quality parameters of fish oil by means of 1 H NMR spectroscopy

Giese, E., Winkelmann, O., Rohn, S., & Fritsche, J. (2016) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201500573 · Cited by 11 · see citing works

A randomized trial comparing omega-3 fatty acid plasma levels after ingestion of emulsified and non-emulsified cod liver oil formulations

Conus, N. M., Burgher-Kennedy, N., van den Berg, F., & Datta, G. K. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1512479 · Cited by 10 · see citing works

Breast cancer during pregnancy.

Saunders, C. M., Hickey, M., & Ives, A. D. (2004) · PubMed · Cited by 10 · see citing works

A study protocol of a randomized trial evaluating the effect of using defined menu plans within an intensive personal nutritional counseling program on cardiovascular risk factors: The MoKaRi (modulation of cardiovascular risk factors) trial

Dawczynski, C., Cullen, P. M., Schlattmann, P., & Stefan Lorkowski, A. (2021) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2021.100761 · Cited by 9 · see citing works

Metabolic effect of docosahexaenoic acid supplementation in different doses and formulations (ethyl- and glyceryl-) in hypercholesterolemic rats

Tabernero, M., Bermejo, L. M., Elvira, M., Caz, V., Baeza, F., Señoráns, F. J., de Miguel, E., & Largó, C. (2013) · Journal of Functional Foods · doi:10.1016/j.jff.2013.01.021 · Cited by 8 · see citing works

Potential Benefits of Omega-3 Polyunsaturated Fatty Acids (N3PUFAs) on Cardiovascular Health Associated with COVID-19: An Update for 2023

Lu, L. W., Quek, S. Y., Lu, S.-P., & Chen, J. (2023) · Metabolites · doi:10.3390/metabo13050630 · Cited by 6 · see citing works

Oxylipin secretion by human CD3+ T lymphocytes in vitro is modified by the exogenous essential fatty acid ratio and life stage

von Gerichten, J., West, A. L., Irvine, N. A., Miles, E. A., Calder, P. C., Lillycrop, K. A., Burdge, G. C., & Fielding, B. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1206733 · Cited by 7 · see citing works

The Role of Antioxidants and Encapsulation Processes in Omega-3 Stabilization

Rahmani-Manglano, N. E., García‐Moreno, P. J., Espejo-Carpio, F. J., Pérez-Gálvez, A. R., & Guadix-Escobar, E. M. (2020) · Food bioactive ingredients · doi:10.1007/978-3-030-62052-3_10 · Cited by 5 · see citing works

US Family Physicians Overestimate Personal ω-3 Fatty Acid Biomarker Status: Associations with Fatty Fish and ω-3 Supplement Intake

Matusheski, N. V., Marshall, K., Hartunian‐Sowa, S., & McBurney, M. I. (2017) · Current Developments in Nutrition · doi:10.3945/cdn.117.002188 · Cited by 5 · see citing works

Coagulation, Thrombogenesis, and Insulin Resistance Markers in Increased-Cardiovascular-Risk Subjects Consuming Improved-Fat Meat Products

Celada, P., Olmedilla‐Alonso, B., Delgado‐Pando, G., Raposo, R., Jiménez-Colmenero, F., Garcimartín, A., & Sánchez-Muniz, F. J. (2019) · Journal of the American College of Nutrition · doi:10.1080/07315724.2018.1513345 · Cited by 5 · see citing works

Nutrient Status and Intakes of Adults with Phenylketonuria

Venegas, E., Langeveld, S., Ahring, K., Benitez, R., Desloovere, A., Dios, E., Gómez, E., Ameijeiras, Á. H., Marsaux, C. F. M., Verloo, P., et al. (2024) · Nutrients · doi:10.3390/nu16162724 · Cited by 4 · see citing works

Comparison of body composition and sensory quality of wild and farmed whitefish (Coregonus macrophthalmus [Nüsslin, 1882])

Goebel, S., Gaye‐Siessegger, J., Baer, J., & Geist, J. P. (2017) · Journal of Applied Ichthyology · doi:10.1111/jai.13318 · Cited by 4 · see citing works

Opportunities within the Agri-food System to Encourage a Nutritionally Balanced Diet– Part II

Pamel, E. V., Cnops, G., Droogenbroeck, B. V., Delezie, E., Royen, G. V., Vlaemynck, G., Bekaert, K. M., Roldán-Ruíz, I., Crivits, M., Bernaert, N., et al. (2020) · Food Reviews International · doi:10.1080/87559129.2020.1717518 · Cited by 4 · see citing works

Opportunities within the Agri-food System to Encourage a Nutritionally Balanced Diet – Part I

Pamel, E. V., Cnops, G., Droogenbroeck, B. V., Delezie, E., Royen, G. V., Vlaemynck, G., Aper, J., Muylle, H., Bekaert, K. M., Cooreman, K., et al. (2020) · Food Reviews International · doi:10.1080/87559129.2020.1719504 · Cited by 4 · see citing works

Evaluation of the effect of a dietary supplementation with a red yeast rice and fish oil-containing nutraceutical on lipid pattern, high sensitivity C-reactive protein, and endothelial function in moderately hypercholesterolaemic subjects: a double-blind, placebo-controlled, randomized clinical trial

Fogacci, F., Giovannini, M., Micoli, V. D., Grandi, E., Veronesi, M., Borghi, C., & Cicero, A. F. G. (2024) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad/177444 · Cited by 4 · see citing works

Applications of Omega-3 Fats in Foods

Hernandez, E. M., & de Jong, L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-893997-82-0.50010-4 · Cited by 4 · see citing works

Nutraceuticals: Health effects and clinical applications

Chen, O., & Mah, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821848-8.00043-3 · Cited by 4 · see citing works

Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐NL‐2010‐85) for authorisation of food and feed containing, consisting of and produced from genetically modified soybean MON 87769 × MON 89788

(GMO), E. P. O. G. M. O., Naegeli, H., Bresson, J., Dalmay, T., Dewhurst, I. C., Epstein, M. M., Firbank, L. G., Guerche, P., Hejátko, J., Moreno, F. J., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6589 · Cited by 3 · see citing works

Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation

Micheli, L., Pacini, A., Mannelli, L. D. C., Trallori, E., D’Ambrosio, R., Bianchini, C., Lampertico, P., & Ghelardini, C. (2020) · Nutrients · doi:10.3390/nu12061819 · Cited by 3 · see citing works

Labelling and claims in foods containing omega-3 fatty acids

Hernandez, E. M. (2013) · Elsevier eBooks · doi:10.1533/9780857098863.4.405 · Cited by 2 · see citing works

Omega 3 Fatty Acids and Bioactive Foods

Ferreri, C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397154-8.00084-1 · Cited by 2 · see citing works

Consumer Communication of Nutrition Science and Impact on Public Health

Richardson, D. P. (2015) · ACS symposium series · doi:10.1021/bk-2015-1207.ch003 · Cited by 1 · see citing works

Omega‐3‐Fettsäuren in Schülerlabor und Unterricht

Seel, M., Huwer, J., Luxenburger-Becker, H., Hempelmann, R., Eilks, I., Garner, N., & Siol, A. (2017) · CHEMKON · doi:10.1002/ckon.201710309 · Cited by 1 · see citing works

Challenges in functional foods development based on bioactive lipids

Machado, M., Freitas, A. C., Pintado, M., & Gomes, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824043-4.00011-7 · Cited by 1 · see citing works

Labeling and Health Claims of Fats and Oils in Foods

Hernandez, E. M., & Kamal‐Eldin, A. (2013) · doi:10.1002/9781118528761.ch14

Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID 530), improved absorption of EPA and DHA (ID 522, 523):contribution to the normal function of the immune system by decreasing the levels of eicosanoids, arachidonic acid-derived mediators and pro-inflammatory cytokines (ID 520, 2914), and “immunomodulating agent” (4690) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Tetens, I. (2010) · Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU)

Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and brain, eye and nerve development (ID 501, 513, 540), maintenance of normal brain function (ID 497, 501, 510, 513, 519, 521, 534, 540, 688, 1323, 1360, 4294), maintenance of normal vision (ID 508, 510, 513, 519, 529, 540, 688, 2905, 4294), maintenance of normal cardiac function (ID 510, 688, 1360), “maternal health; pregnancy and nursing” (ID 514), “to fulfil increased omega‐3 fatty acids need during pregnancy” (ID 539), “skin and digestive tract epithelial cells maintenance” (ID 525), enhancement of mood (ID 536), “membranes cell structure” (ID 4295), “anti‐inflammatory action” (ID 4688) and maintenance of normal blood LDL‐cholesterol concentrations (ID 4719) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Panel on Dietetic Products, N. A. A. (. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.2078 · Cited by 35 · see citing works

Scientific Opinion on the substantiation of health claims related to EPA, DHA, DPA and maintenance of normal blood pressure (ID 502), maintenance of normal HDL-cholesterol concentrations (ID 515), maintenance of normal (fasting) blood concentrations of tr

EFSA Panel on Dietetic Products, N. A. A. (. (2009) · EFSA Journal · doi:10.2903/j.efsa.2009.1263 · Cited by 33 · see citing works

Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contr

EFSA Panel on Dietetic Products, N. A. A. (. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1734 · Cited by 21 · see citing works

Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA) and maintenance of normal (fasting) blood concentrations of triglycerides (ID 533, 691, 3150), protection of blood lipids from oxidative damage (ID 630), contribution to the maintenance or achievement of a normal body weight (ID 629), brain, eye and nerve development (ID 627, 689, 704, 742, 3148, 3151), maintenance of normal brain function (ID 565, 626, 631, 689, 690, 704, 742, 3148, 3151), maintenance of normal vision (ID 627, 632, 743, 3149) and maintenance of normal spermatozoa motility (ID 628) pursuant to Article 13(1) of Regulation (EC) No 1924/2006:EFSA-Q-2008-1320, EFSA-Q-2008-1416, EFSA-Q-2008-1417, EFSA-Q-2008-1478, EFSA-Q-2008-3882 , EFSA-Q-2008-1352, EFSA-Q-2008-1413, EFSA-Q-2008-1414, EFSA-Q-2008-1415, EFSA-Q-2008-1418, EFSA-Q-2008-1419, EFSA-Q-2008-1476, EFSA-Q-2008-1477, EFSA-Q-2008-1491, EFSA-Q-2008-1529, EFSA-Q-2008-1530, EFSA-Q-2008-3880, EFSA-Q-2008-3881, EFSA-Q-2008-3883

Tetens, I. (2010) · Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU)